In 2016, the World Health Organization (WHO) classifications introduced “AML with mutated RUNX1 (RUNX1mut)” as a provisional entity to AML with a recurrent genetic abnormalities subtype because RUNX1mut patients had distinct clinical and genetic markers [8,9,10]. Here, RUNX1 is linked to acute myeloid leukemia.